CHELMSFORD, Mass.--(BUSINESS WIRE)--
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to enter the Japanese market with its Intravascular Temperature Management (IVTM™) technology—the first intravascular temperature management system to receive Shonin approval in Japan.
ZOLL’s IVTM solution will be marketed and sold by Asahi Kasei ZOLL Medical (AZM), a ZOLL company established in August 2012 to pursue the regulatory approval, sale, and marketing of ZOLL products in Japan.
ZOLL’s IVTM technology was approved in Japan for fever control in neurologically injured patients. The intravascular system offers superior temperature control when compared to other cooling methods. Fever is commonly found in both neurologically injured and neurosurgical patients and is associated with poor outcomes.1 Specifically, moderate fever has been reported to almost double patient mortality, while extremely high fever can triple mortality.2 Management of the body’s core temperature is key to proper neurological function, especially for patients in neurointensive care.
ZOLL’s IVTM system provides cooling and warming through a balloon catheter inserted into the venous system. This provides better control of the core body temperature over surface methods by directly cooling or warming the patient’s blood as it flows through the body. This catheter is connected to the Thermogard XP® console, which circulates cold saline solution inside the catheter. Since the saline flows only within the catheter, no fluid is infused into the patient. ZOLL offers a variety of triple-lumen catheters with placement options to handle specific patient challenges. The ZOLL IVTM system is efficient, precise, and easy to use, and frees up clinical staff to attend to other patient needs.
“We are very excited to begin commercialization of IVTM in Japan and to continue to offer innovative technologies and devices for critical care to this high-growth market,” said James Palazzolo, President of ZOLL Sunnyvale (Calif.) operations. “We are now preparing for a clinical trial for therapeutic hypothermia following cardiopulmonary resuscitation, a treatment having a Class 1 recommendation3 from both the American Heart Association (AHA) and the Japan Resuscitation Council (JRC).
Other ZOLL products sold in Japan:
- The AED Plus®—an automated external defibrillator (AED) that incorporates ZOLL’s real-time CPR feedback technology, Real CPR Help®, which assists rescuers in delivering high-quality CPR to sudden cardiac arrest victims. The AED Plus is the only AED with CPR feedback capability available in the Japanese market.
- The AutoPulse® Non-invasive Cardiac Support Pump—a unique mechanical CPR system that employs a load-distributing band to provide consistent, uninterrupted, high-quality chest compressions.
- Pocket CPR®—an easy-to-use portable device that uses Real CPR Help to provide real-time audible and visual feedback on the depth and rate of chest compressions, guiding rescuers to meet current guidelines.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
Copyright © 2013 ZOLL Medical Corporation. All rights reserved. AED Plus, AutoPulse, Pocket CPR, IVTM, Real CPR Help, Thermogard, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.
1 Diringer MN, et al. Crit Care Med (2004) 32, 2:559–564.
2 Diringer MN, et al. Crit Care Med (2004) 32, 7:1489–1495.
3 2010 AHA Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care and JRC 2010 Guidelines. Class I: Procedure/treatment should be performed/administered, Class IIa: It is reasonable to perform procedure/administer treatment, Class IIb: Procedure/treatment may be considered, Class III: Procedure/treatment should not be performed/administered since it is not helpful and may be harmful.
- Technology & Electronics
- Asahi Kasei
Diane Egan, +1-978-421-9637
Recommended for You
Now can we call Ford Motor (F) a wreck? Shares of Ford have continued to plunge today following yesterday's gloomy earnings guidance, and are now down 8% this week. Toyota Motor (TM) has declined just 0.6% this week, while General Motors (GM) has ticked up 0.3% and Honda Motor (HMC) has advanced…Barrons.com
Target is grappling with a data security nightmare that threatens to drive off holiday shoppers during the company's busiest time of year. The nation's second largest discounter said Thursday that data ...Associated Press
Facebook chief Mark Zuckerberg will sell a chunk of his stake in the company, cashing in some $2.3 billion, as part of a new share offering by the huge social network. A Facebook filing Thursday said the company would sell 70 million shares in a follow-on offering to the huge initial public…AFP
The United States travel and tourism industry is one of the fastest growing sectors and doesn't seem to be slowing down.CNBC
By Jonathan Stempel NEW YORK (Reuters) - A U.S. appeals court on Thursday revived claims by families of victims of the September 11, 2001, attacks who alleged that Saudi Arabia provided material support to al Qaeda. Reversing a lower court ruling, the 2nd U.S. Circuit Court of Appeals in New York…Reuters
It's the question we all dread. Sometimes it...Business Insider
By Thomas Escritt AMSTERDAM (Reuters) - Prosecutors at the International Criminal Court said on Thursday they did not have enough evidence to proceed with their case against Kenyan President Uhuru Kenyatta, and asked judges to postpone it indefinitely. The development is a major setback to the…Reuters
India on Thursday allowed Reliance Industries (NSI:RELIANCE.NS - News) to charge higher prices for gas from April after the company offered financial guarantees to the government to settle any claims against it over a shortfall in its gas output. In June, India approved a move to higher,…Reuters
Millions of consumers are now asking themselves what they need to do to reduce their risk of fraud.WPVI – Philadelphia
Earlier this month, someone pulled off the largest heist in the history of Bitcoin, the virtual currency that approximates cash on the internet. The illegal drug bazaar Sheep Marketplace was plundered, either by hackers or insiders, and about $100 million worth of the currency was stolen from…The Verge
Inc., the world's top two television makers, said in separate statements Thursday that they will unveil their own 105-inch curved TVs at the U.S. Consumer Electronics Show in January. Samsung and LG were eventually forced to sell the TVs at discounts after limited consumer interest. Samsung said…The Wall Street Journal
These companies should be able to cash in on the increase in jet sales.Forbes
When a pharmaceutical company is successful, it can then afford to do things like donate medicines to cure blindness in sub-Saharan Africa, as Pfizer and Merck are doing. They can set up research centers in India to find new treatments for TB (AstraZeneca) or in Singapore to study tropical diseases…Forbes
When the Fed decides to wind down the quantitative easing program known as QE3, investors aren’t the only ones who will feel the pinch.MarketWatch
U.S. markets ended mixed on Thursday but gold prices closed at their lowest level in more than three years and oil prices climbed to their highest level since October. Meanwhile, Target shares took a hit on word the big box retailer suffered a data breech.TheStreet.com Videos
To here many pundits talk, business owners and the wealthy aren't paying enough in taxes. The numbers show the opposite is true.Entrepreneur
Here are strategies that will serve you well in 2014 — and perhaps longer — that you should have learned if you were paying attention over the past 12 months.MarketWatch
Tesla Motors Inc has started offering its poplar Model S sedans in China, but the U.S. premium electric carmaker has yet to give its brand a Chinese name due to a long-running trademark dispute. That has caused a buzz online with enthusiasts avidly guessing how Tesla will be named locally and even…Reuters
We're still in the part of the year when the...Business Insider
Oracle shares jumped 6% after the company released seemingly tepid results for its fiscal second quarter. Beneath the surface, some investors saw positive signs that Oracle is increasingly meeting the challenge of its cloud-service based competitors.The Exchange